Talk:Insulin glulisine
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Insulin glulisine.
|
WikiProject class rating
[edit]This article was automatically assessed because at least one WikiProject had rated the article as start, and the rating on other projects was brought up to start class. BetacommandBot 16:28, 10 November 2007 (UTC)
Insulin glulisine has the similar advantages to other insulin analogues over ordinary insulin including: Better control of meal-time glycaemia, lower incidence of postprandial hypoglycaemia & greater reducing in HbA1c (use for assessment of diabetes mellitus treatment) than regular insulin —Preceding unsigned comment added by 41.236.235.48 (talk) 14:34, 6 May 2010 (UTC)
really need an expert?
[edit]The topic is marked as needing an expert in pharmacology. While this would be ideal, the main issue is that the article is only a stub. A knowledgeable non-expert could improve it greatly. (I could do it but unfortunately I don't have time.) Paleolith (talk) 20:53, 16 September 2012 (UTC)